Dr Parkes trained at Queens University Belfast, completing her oncology fellowship training at the Northern Ireland Cancer Centre. During her training she was awarded a CRUK clinical fellowship, and completed her DPhil in the Kennedy lab, studying the immune consequences of DNA repair deficiency. During this time she discovered constitutive STING signaling in DNA repair deficient cancers. Eileen joined the Department of Oncology, in Oxford University, as a Clinical Career Development Fellow in September 2019. She now focuses on understanding how to exploit the consequences of STING signaling for clinical benefit.